Illumina · 1 month ago
Sr Director/ Sr Principal Scientist, Protein Engineering
Illumina is a global leader in genomics, dedicated to advancing healthcare through continuous innovation. The company is seeking a visionary leader for the Advanced Sciences department in protein engineering to provide strategic and technical leadership, influence technology roadmaps, and drive the development of innovative products.
BiotechnologyGeneticsHealth CareMedical
Responsibilities
Shape and communicate the strategic vision for the protein engineering group, leading teams to execute on that vision
Evaluate product needs in the marketplace and provide strategic research direction for protein/enzyme improvements to enhance existing and novel products
Analyze internal and external assay capabilities to help create a market-leading product portfolio
Develop strategies to ensure effective and efficient achievement of company objectives for genomics and multiomics markets as they pertain to protein engineering
Translate strategy into executable operating plans, collaborating with peers across the organization to align and execute on strategic roadmaps
Establish cross-department and cross-functional collaborations to ensure project and program needs are met by the protein engineering team
Lead technology research and development teams in a highly matrixed organization
Manage and/or influence program and project leaders to ensure progress on multiple projects and programs remains on track
Develop and manage budgets for large capital expenditures and labor costs
Maintain a comprehensive understanding of NGS workflows, from sample acquisition to data analysis
Understand molecular details of NGS systems, including library preparation and sequencing chemistry
Write and review publications (e.g., marketing collateral, scientific papers) and present to the Illumina executive team, board of directors, and at scientific conferences
Qualification
Required
Expertise in the latest protein engineering techniques and methods; familiarity with DNA polymerases, transposases, reverse transcriptases, nanopores and other nucleic acid binding or modifying enzymes
Demonstrated leadership skills with a track record of developing and mentoring senior leaders and individual contributors in diverse contexts
Deep knowledge of Next Generation Sequencing (NGS) and hands-on experience with library preparation for Illumina sequencing systems or other sequencing technologies
Experience in taking conceptual research through development to a viable product for commercialization
Strong program and project management skills, including scope, scheduling, budget, and resource management
Excellent presentation skills for diverse audiences
PhD in Biological Sciences, Chemical Biology or equivalent experience
Typically requires a Bachelor's degree and a minimum of 20 years of related experience, with 12+ years of Management experience
Experience managing and mentoring senior-level PhD scientists across various disciplines while overseeing product development projects
Broad knowledge of all areas within protein engineering
Deep technical knowledge in a variety of functions, gained from experience in both non-management and management roles
Benefits
Access to genomics sequencing
Family planning
Health/dental/vision
Retirement benefits
Paid time off
Company
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
H1B Sponsorship
Illumina has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (134)
2024 (116)
2023 (159)
2022 (180)
2021 (123)
2020 (111)
Funding
Current Stage
Public CompanyTotal Funding
$1.28BKey Investors
Bank of America
2024-09-06Post Ipo Debt· $500M
2023-01-04Post Ipo Debt· $750M
2000-07-28IPO
Leadership Team
Recent News
businessweekly.co.uk
2026-01-11
BioWorld Financial Watch
2026-01-11
Company data provided by crunchbase